Angiopoietin-like 3 Is a Potential Biomarker for Retinopathy in Type 2 Diabetic Patients.
暂无分享,去创建一个
Ying-Mei Feng | Shaozhen Zhao | Da-wei Zhang | Cai‐Guo Yu | S. Yuan | Longyan Yang | Jing Ke | Lijie Zhang | Jianan Lang | Dong Zhao | Li-jie Zhang | Long-yan Yang | D. Zhao
[1] Ying-Mei Feng,et al. Angiopoietin‐Like Protein 4 Is a High‐Density Lipoprotein (HDL) Component for HDL Metabolism and Function in Nondiabetic Participants and Type‐2 Diabetic Patients , 2017, Journal of the American Heart Association.
[2] J. Jumper,et al. Anti-VEGF treatment of diabetic macular edema in clinical practice: effectiveness and patterns of use (ECHO Study Report 1) , 2017, Clinical ophthalmology.
[3] A. Fusco,et al. A polymorphism of HMGA1 protects against proliferative diabetic retinopathy by impairing HMGA1-induced VEGFA expression , 2016, Scientific Reports.
[4] S. Ricard-Blum,et al. ANGPTL4–αvβ3 interaction counteracts hypoxia‐induced vascular permeability by modulating Src signalling downstream of vascular endothelial growth factor receptor 2 , 2016, The Journal of pathology.
[5] Zongwei Wang,et al. Different relationship between ANGPTL3 and HDL components in female non-diabetic subjects and type-2 diabetic patients , 2016, Cardiovascular Diabetology.
[6] Bin Chen,et al. ANGPTL-4 correlates with vascular endothelial growth factor in patients with proliferative diabetic retinopathy , 2016, Graefe's Archive for Clinical and Experimental Ophthalmology.
[7] Ren Zhang. The ANGPTL3-4-8 model, a molecular mechanism for triglyceride trafficking , 2016, Open Biology.
[8] T. Peto,et al. Prevalence of diabetic retinopathy in screening-detected diabetes mellitus: results from the Gutenberg Health Study (GHS) , 2015, Diabetologia.
[9] Sharon D. Solomon,et al. Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy , 2015, Proceedings of the National Academy of Sciences.
[10] Soo Hyun Kwon,et al. Aqueous Levels of Angiopoietin-like 4 and Semaphorin 3E Correlate with Nonperfusion Area and Macular Volume in Diabetic Retinopathy. , 2015, Ophthalmology.
[11] M. Reilly,et al. Differential Association of Plasma Angiopoietin-Like Proteins 3 and 4 With Lipid and Metabolic Traits , 2014, Arteriosclerosis, thrombosis, and vascular biology.
[12] Wei Sun,et al. Tanshinone II a protects against lipopolysaccharides-induced endothelial cell injury via Rho/Rho kinase pathway , 2014, Chinese Journal of Integrative Medicine.
[13] G. Santulli. Angiopoietin-Like Proteins: A Comprehensive Look , 2014, Front. Endocrinol..
[14] G. Opdenakker,et al. Expression of lysophosphatidic acid, autotaxin and acylglycerol kinase as biomarkers in diabetic retinopathy , 2013, Acta Diabetologica.
[15] L. Keinan-Boker,et al. A decrease in VEGF and inflammatory markers is associated with diabetic proliferative retinopathy. , 2012, European cytokine network.
[16] Z. Shan,et al. Prevalence of Diabetic Retinopathy in Mainland China: A Meta-Analysis , 2012, PloS one.
[17] Xiuqing Guo,et al. Systemic soluble tumor necrosis factor receptors 1 and 2 are associated with severity of diabetic retinopathy in Hispanics. , 2012, Ophthalmology.
[18] Sander Kersten,et al. Regulation of triglyceride metabolism by Angiopoietin-like proteins. , 2012, Biochimica et biophysica acta.
[19] F. Bandello,et al. The Role of Angiogenesis in the Development of Proliferative Diabetic Retinopathy: Impact of Intravitreal Anti-VEGF Treatment , 2012, Experimental diabetes research.
[20] K. Geboes,et al. High-mobility group box-1 and biomarkers of inflammation in the vitreous from patients with proliferative diabetic retinopathy , 2011, Molecular vision.
[21] Asaad A. Ghanem,et al. Pentosidine and N-Carboxymethyl-Lysine: Biomarkers for Type 2 Diabetic Retinopathy , 2011, European journal of ophthalmology.
[22] G. Lizard,et al. Immunohistochemical analysis of cellular adhesion molecules (ICAM-1, VCAM-1) and VEGF in fibrovascular membranes of patients with proliferative diabetic retinopathy: preliminary study. , 2009, Pathologie-biologie.
[23] C. Rivard,et al. Abnormal Angiogenesis in Diabetic Nephropathy , 2009, Diabetes.
[24] G. Camenisch,et al. ANGPTL3 Stimulates Endothelial Cell Adhesion and Migration via Integrin αvβ3 and Induces Blood Vessel Formation in Vivo * , 2002, The Journal of Biological Chemistry.
[25] Grading diabetic retinopathy from stereoscopic color fundus photographs--an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group. , 1991, Ophthalmology.